Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

X-Inactivation01:58

X-Inactivation

42.3K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.3K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

11.5K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.5K
What are Viruses?00:50

What are Viruses?

128.3K
Overview
128.3K
Continuing Care01:25

Continuing Care

2.0K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
Continuity of a Function01:23

Continuity of a Function

248
A function is continuous at a point a if three conditions are met: the function is defined at a, the limit of the function as x approaches a exists, and this limit equals the function’s value. Mathematically, this is written asThis definition ensures the graph of the function does not exhibit any breaks, holes, or jumps at that point. Discontinuities occur when any of these conditions fail. A removable discontinuity exists when the two-sided limit exists but the function is either...
248

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Yield Production and Cost-Effective Purification of an Alkali-Resistant Hexameric Protein A Variant for Antibody Affinity Chromatography.

Biotechnology journal·2026
Same author

The impact of unspecific viral adsorption on pharmaceutical container surfaces in vaccine process development.

Vaccine·2026
Same author

One-pot expression of an oligoclonal nanobody-based antivenom in growth-decoupled Escherichia coli.

Trends in biotechnology·2026
Same author

Engineered Bacterial Ligand From Streptococcus pneumoniae on Macroporous Resins for Selective Affinity Capture of Secretory IgA.

Biotechnology and bioengineering·2026
Same author

Cytokine-based rapid process control of live virus production: MCP-1 as a cross-family biomarker in Vero cells.

Journal of virological methods·2026
Same author

Modeling retention time distribution in continuous Protein A affinity capture for materials traceability and diversion: A case study with twin-column system.

Journal of chromatography. A·2026

Related Experiment Video

Updated: Feb 5, 2026

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

4.2K

Continuous Virus Inactivation: How to Generate a Plug Flow.

Alois Jungbauer1

  • 1Department of Biotechnology, University of Natural Resources and Life Sciences, 1190, Vienna, Austria.

Biotechnology Journal
|September 13, 2018
PubMed
Summary

Continuous biopharmaceutical manufacturing requires all steps, including virus inactivation, to operate continuously. This summary highlights innovative solutions for optimizing virus inactivation processes, a key challenge in continuous production.

Keywords:
IgGantibodycontinuousintegrated biomanufacturinglow pHvirus

More Related Videos

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.5K
Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid
07:06

Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid

Published on: November 15, 2017

12.1K

Related Experiment Videos

Last Updated: Feb 5, 2026

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

4.2K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.5K
Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid
07:06

Continuous Flow Chemistry: Reaction of Diphenyldiazomethane with p-Nitrobenzoic Acid

Published on: November 15, 2017

12.1K

Area of Science:

  • Biopharmaceutical Manufacturing
  • Process Engineering
  • Viral Safety

Background:

  • Continuous integrated manufacturing is essential for biopharmaceuticals.
  • Virus inactivation is a critical but challenging step in continuous processes due to fixed residence times.
  • Standard virus inactivation procedures hinder seamless integration into continuous workflows.

Purpose of the Study:

  • To address the challenge of integrating virus inactivation into continuous biopharmaceutical manufacturing.
  • To present novel solutions for optimizing virus inactivation in a continuous production setting.
  • To facilitate the realization of fully continuous biopharmaceutical production.

Main Methods:

  • Review and analysis of innovative approaches for virus inactivation.
  • Evaluation of methods enabling continuous operation and variable residence times.
  • Exploration of process modifications for seamless integration.

Main Results:

  • Identified potential solutions for continuous virus inactivation.
  • Demonstrated feasibility of adapting virus inactivation to continuous workflows.
  • Highlighted strategies to overcome residence time limitations.

Conclusions:

  • Continuous virus inactivation is achievable with innovative strategies.
  • The presented solutions support the development of fully continuous biopharmaceutical manufacturing.
  • Optimizing virus inactivation is key to advancing integrated bioprocessing.